Quarterly
Annual
| Unit: USD | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows — operating activities: | |||||||||||||||||||||||||||||||||||
net income | 652,000,000 | 327,000,000 | -268,000,000 | 490,000,000 | 1,837,000,000 | 467,000,000 | 18,000,000 | -184,000,000 | 502,000,000 | 476,000,000 | 698,000,000 | -248,000,000 | 679,000,000 | -1,357,000,000 | -284,000,000 | 730,000,000 | 10,000,000 | 36,000,000 | -2,040,000,000 | -27,000,000 | 442,000,000 | 164,000,000 | 45,000,000 | 234,000,000 | 114,000,000 | 354,000,000 | 224,000,000 | -186,000,000 | 331,000,000 | 105,000,000 | -306,000,000 | -579,000,000 | 273,000,000 | -26,000,000 | 78,000,000 |
adjustments to reconcile net income to cash from operating activities: | |||||||||||||||||||||||||||||||||||
depreciation and amortization | 691,000,000 | 762,000,000 | 772,000,000 | 740,000,000 | 714,000,000 | 622,000,000 | 555,000,000 | 514,000,000 | 501,000,000 | 464,000,000 | 477,000,000 | 472,000,000 | 521,000,000 | 512,000,000 | 542,000,000 | 499,000,000 | 582,000,000 | 458,000,000 | 511,000,000 | 536,000,000 | 490,000,000 | 533,000,000 | 489,000,000 | 482,000,000 | 508,000,000 | 425,000,000 | 461,000,000 | 463,000,000 | 451,000,000 | 439,000,000 | 180,000,000 | 214,000,000 | 184,000,000 | 211,000,000 | 226,000,000 |
deferred income tax benefit | 196,000,000 | 57,000,000 | -185,000,000 | -23,000,000 | 20,000,000 | 147,000,000 | 109,000,000 | 181,000,000 | -61,000,000 | 203,000,000 | -417,000,000 | -84,000,000 | 112,000,000 | 39,000,000 | -102,000,000 | -524,000,000 | |||||||||||||||||||
impairment of long-lived and other assets | 5,000,000 | 0 | 0 | 0 | 49,000,000 | ||||||||||||||||||||||||||||||
unrealized net (gain) income from mark-to-market valuations of commodities | -46,000,000 | 176,000,000 | 365,000,000 | 284,000,000 | -54,000,000 | -1,085,000,000 | 360,000,000 | -12,000,000 | 589,000,000 | -71,000,000 | 78,000,000 | -517,000,000 | -186,000,000 | 173,000,000 | 8,000,000 | ||||||||||||||||||||
unrealized net income from mark-to-market valuations of interest rate swaps | -26,000,000 | -11,000,000 | 18,000,000 | 174,000,000 | |||||||||||||||||||||||||||||||
unrealized net gain from nuclear decommissioning trusts | -90,000,000 | 17,000,000 | -78,000,000 | -27,000,000 | -28,000,000 | ||||||||||||||||||||||||||||||
asset retirement obligation accretion expense | 34,000,000 | 32,000,000 | 34,000,000 | 30,000,000 | 32,000,000 | 33,000,000 | 19,000,000 | 8,000,000 | 9,000,000 | 8,000,000 | 9,000,000 | 8,000,000 | 9,000,000 | 8,000,000 | 9,000,000 | 11,000,000 | 8,000,000 | 8,000,000 | 11,000,000 | 10,000,000 | 10,000,000 | 11,000,000 | 12,000,000 | 13,000,000 | 13,000,000 | 13,000,000 | 14,000,000 | ||||||||
bad debt expense | 65,000,000 | 43,000,000 | 44,000,000 | 51,000,000 | 60,000,000 | 36,000,000 | 36,000,000 | 33,000,000 | 62,000,000 | 34,000,000 | 35,000,000 | 43,000,000 | |||||||||||||||||||||||
stock-based compensation expense | 36,000,000 | 25,000,000 | 21,000,000 | ||||||||||||||||||||||||||||||||
involuntary conversion gain | 0 | ||||||||||||||||||||||||||||||||||
other | 23,000,000 | -44,000,000 | 57,000,000 | -80,000,000 | 14,000,000 | 0 | -23,000,000 | 64,000,000 | 15,000,000 | 16,000,000 | 8,000,000 | 34,000,000 | 32,000,000 | -38,000,000 | 23,000,000 | 45,000,000 | 11,000,000 | -137,000,000 | 60,000,000 | 52,000,000 | 3,000,000 | -24,000,000 | -61,000,000 | 105,000,000 | -32,000,000 | 28,000,000 | 70,000,000 | -13,000,000 | 7,000,000 | -15,000,000 | 62,000,000 | 0 | 22,000,000 | ||
changes in operating assets and liabilities: | |||||||||||||||||||||||||||||||||||
margin deposits | 7,000,000 | -151,000,000 | -217,000,000 | -13,000,000 | 422,000,000 | 305,000,000 | 128,000,000 | -372,000,000 | 257,000,000 | 787,000,000 | 1,227,000,000 | -69,000,000 | 88,000,000 | -2,103,000,000 | 210,000,000 | -233,000,000 | -527,000,000 | -106,000,000 | -134,000,000 | -80,000,000 | 2,000,000 | -41,000,000 | 99,000,000 | 41,000,000 | 17,000,000 | 78,000,000 | 34,000,000 | -182,000,000 | 22,000,000 | 3,000,000 | -64,000,000 | -37,000,000 | 36,000,000 | 34,000,000 | 113,000,000 |
accrued interest | 37,000,000 | -56,000,000 | 51,000,000 | -29,000,000 | 7,000,000 | 7,000,000 | -3,000,000 | 93,000,000 | -43,000,000 | 43,000,000 | -47,000,000 | 47,000,000 | -44,000,000 | 75,000,000 | -62,000,000 | 68,000,000 | -63,000,000 | 83,000,000 | -75,000,000 | 77,000,000 | -91,000,000 | 71,000,000 | -77,000,000 | 65,000,000 | 9,000,000 | -9,000,000 | 15,000,000 | -46,000,000 | 15,000,000 | -63,000,000 | -11,000,000 | 16,000,000 | 3,000,000 | 2,000,000 | -31,000,000 |
accrued taxes | 37,000,000 | 53,000,000 | -109,000,000 | 39,000,000 | 18,000,000 | 53,000,000 | -111,000,000 | 43,000,000 | 14,000,000 | 39,000,000 | -91,000,000 | 38,000,000 | 16,000,000 | 36,000,000 | -98,000,000 | 43,000,000 | 12,000,000 | 4,000,000 | -79,000,000 | 57,000,000 | 24,000,000 | 51,000,000 | -110,000,000 | 27,000,000 | 36,000,000 | 8,000,000 | -75,000,000 | 38,000,000 | 10,000,000 | -43,000,000 | -69,000,000 | 77,000,000 | |||
accrued employee incentive | 39,000,000 | 32,000,000 | -177,000,000 | 86,000,000 | 62,000,000 | 29,000,000 | -169,000,000 | 81,000,000 | 34,000,000 | 22,000,000 | -79,000,000 | 38,000,000 | 21,000,000 | 21,000,000 | -59,000,000 | 18,000,000 | 21,000,000 | 21,000,000 | -128,000,000 | 59,000,000 | 50,000,000 | 20,000,000 | -90,000,000 | 54,000,000 | 19,000,000 | 18,000,000 | -90,000,000 | ||||||||
other operating assets and liabilities | -91,000,000 | -417,000,000 | -54,000,000 | -189,000,000 | -442,000,000 | -232,000,000 | -247,000,000 | -245,000,000 | -75,000,000 | -266,000,000 | -663,000,000 | 56,000,000 | -93,000,000 | -226,000,000 | 999,000,000 | -35,000,000 | -207,000,000 | -15,000,000 | 22,000,000 | -226,000,000 | -136,000,000 | -156,000,000 | -277,000,000 | -25,000,000 | |||||||||||
cash from operating activities | 1,467,000,000 | 572,000,000 | 599,000,000 | 1,353,000,000 | 1,702,000,000 | 1,196,000,000 | 312,000,000 | 881,000,000 | 1,560,000,000 | 1,577,000,000 | 1,435,000,000 | 393,000,000 | 815,000,000 | -1,314,000,000 | 591,000,000 | 287,000,000 | 564,000,000 | 596,000,000 | -1,653,000,000 | 987,000,000 | 1,041,000,000 | 757,000,000 | 552,000,000 | 913,000,000 | 941,000,000 | 494,000,000 | 388,000,000 | 608,000,000 | 892,000,000 | -7,000,000 | -22,000,000 | 541,000,000 | 512,000,000 | 192,000,000 | 141,000,000 |
cash flows — investing activities: | |||||||||||||||||||||||||||||||||||
capital expenditures, including nuclear fuel purchases and ltsa prepayments | -458,000,000 | -690,000,000 | -768,000,000 | -430,000,000 | -685,000,000 | -498,000,000 | -465,000,000 | -414,000,000 | -336,000,000 | -442,000,000 | -484,000,000 | -392,000,000 | -296,000,000 | -240,000,000 | -373,000,000 | -243,000,000 | -244,000,000 | -354,000,000 | -192,000,000 | -421,000,000 | -250,000,000 | -327,000,000 | -261,000,000 | ||||||||||||
free cash flows | 1,009,000,000 | -118,000,000 | -169,000,000 | 923,000,000 | 1,017,000,000 | 698,000,000 | -153,000,000 | 467,000,000 | 1,224,000,000 | 1,135,000,000 | 951,000,000 | 1,000,000 | 519,000,000 | -1,554,000,000 | 218,000,000 | 44,000,000 | 320,000,000 | 242,000,000 | -1,845,000,000 | 566,000,000 | 791,000,000 | 430,000,000 | 291,000,000 | ||||||||||||
energy harbor acquisition | 0 | 0 | 5,000,000 | -3,070,000,000 | |||||||||||||||||||||||||||||||
proceeds from sales of nuclear decommissioning trust fund securities | 1,096,000,000 | 917,000,000 | 2,107,000,000 | 643,000,000 | 796,000,000 | 563,000,000 | 214,000,000 | 123,000,000 | 227,000,000 | 132,000,000 | 119,000,000 | 242,000,000 | 94,000,000 | 236,000,000 | 98,000,000 | 117,000,000 | 99,000,000 | 134,000,000 | 133,000,000 | 142,000,000 | 67,000,000 | 149,000,000 | 75,000,000 | 77,000,000 | 62,000,000 | 214,000,000 | 78,000,000 | 41,000,000 | 118,000,000 | 47,000,000 | 46,000,000 | 98,000,000 | 56,000,000 | 19,000,000 | 79,000,000 |
investments in nuclear decommissioning trust fund securities | -1,103,000,000 | -923,000,000 | -2,112,000,000 | -649,000,000 | -802,000,000 | -568,000,000 | -220,000,000 | -129,000,000 | -233,000,000 | -137,000,000 | -125,000,000 | -247,000,000 | -101,000,000 | -242,000,000 | -103,000,000 | -123,000,000 | -105,000,000 | -139,000,000 | -138,000,000 | -148,000,000 | -73,000,000 | -154,000,000 | -80,000,000 | -83,000,000 | -68,000,000 | -219,000,000 | -83,000,000 | -47,000,000 | -124,000,000 | -52,000,000 | -51,000,000 | -103,000,000 | -62,000,000 | -23,000,000 | -84,000,000 |
proceeds from sales of environmental allowances | 32,000,000 | 4,000,000 | 21,000,000 | 626,000,000 | 82,000,000 | 48,000,000 | 17,000,000 | 441,000,000 | 12,000,000 | 12,000,000 | 35,000,000 | 917,000,000 | 92,000,000 | 259,000,000 | 7,000,000 | 290,000,000 | 38,000,000 | 19,000,000 | 45,000,000 | 74,000,000 | 3,000,000 | 14,000,000 | 74,000,000 | ||||||||||||
purchases of environmental allowances | -119,000,000 | -85,000,000 | -307,000,000 | -715,000,000 | -152,000,000 | -228,000,000 | -131,000,000 | -794,000,000 | -87,000,000 | -129,000,000 | -61,000,000 | -960,000,000 | -85,000,000 | -142,000,000 | -116,000,000 | -358,000,000 | -74,000,000 | -145,000,000 | -28,000,000 | -294,000,000 | -37,000,000 | -67,000,000 | -106,000,000 | -153,000,000 | -31,000,000 | ||||||||||
insurance proceeds for recovery of damaged property, plant and equipment | 25,000,000 | ||||||||||||||||||||||||||||||||||
proceeds from sale of property, plant and equipment, including nuclear fuel | 8,000,000 | 2,000,000 | 127,000,000 | ||||||||||||||||||||||||||||||||
cash from investing activities | -491,000,000 | -610,000,000 | -1,061,000,000 | -317,000,000 | -762,000,000 | -669,000,000 | -3,528,000,000 | -763,000,000 | -415,000,000 | -454,000,000 | -513,000,000 | -353,000,000 | -277,000,000 | -129,000,000 | -480,000,000 | -310,000,000 | -268,000,000 | -446,000,000 | -129,000,000 | -645,000,000 | -274,000,000 | -369,000,000 | -284,000,000 | -738,000,000 | -580,000,000 | -250,000,000 | -149,000,000 | -234,000,000 | -109,000,000 | 319,000,000 | -77,000,000 | 56,000,000 | -434,000,000 | -113,000,000 | -50,000,000 |
cash flows — financing activities: | |||||||||||||||||||||||||||||||||||
issuances of debt | 215,000,000 | ||||||||||||||||||||||||||||||||||
repayments/repurchases of debt | -7,000,000 | -751,000,000 | -6,000,000 | -18,000,000 | -1,163,000,000 | -350,000,000 | -756,000,000 | -12,000,000 | -7,000,000 | -7,000,000 | -7,000,000 | -19,000,000 | -9,000,000 | -91,000,000 | -132,000,000 | -147,000,000 | -133,000,000 | -65,000,000 | -36,000,000 | -53,000,000 | -199,000,000 | -533,000,000 | -223,000,000 | -2,441,000,000 | -531,000,000 | -2,855,000,000 | -1,282,000,000 | -173,000,000 | -1,564,000,000 | -1,328,000,000 | -10,000,000 | -159,000,000 | -8,000,000 | -11,000,000 | -13,000,000 |
net borrowings under accounts receivable financing | 875,000,000 | 175,000,000 | -100,000,000 | 225,000,000 | 500,000,000 | -186,000,000 | -64,000,000 | 425,000,000 | |||||||||||||||||||||||||||
borrowings under revolving credit facility | 0 | 0 | 0 | 0 | 100,000,000 | 250,000,000 | 0 | 150,000,000 | 0 | 0 | 1,300,000,000 | 0 | 150,000,000 | 500,000,000 | 425,000,000 | ||||||||||||||||||||
repayments under revolving credit facility | 0 | 0 | 0 | 0 | -350,000,000 | 0 | -250,000,000 | -150,000,000 | 0 | -300,000,000 | -1,000,000,000 | 0 | -700,000,000 | -650,000,000 | -75,000,000 | ||||||||||||||||||||
borrowings under commodity-linked facility | 0 | 0 | 1,302,000,000 | 0 | 500,000,000 | 400,000,000 | 0 | ||||||||||||||||||||||||||||
repayments under commodity-linked facility | -861,000,000 | 0 | -1,302,000,000 | 0 | 0 | 0 | -400,000,000 | 0 | -1,050,000,000 | ||||||||||||||||||||||||||
debt issuance costs | -44,000,000 | 0 | -30,000,000 | -23,000,000 | |||||||||||||||||||||||||||||||
stock repurchases | -187,000,000 | -252,000,000 | -337,000,000 | -245,000,000 | -399,000,000 | -331,000,000 | -291,000,000 | ||||||||||||||||||||||||||||
dividends paid to common stockholders | -77,000,000 | -69,000,000 | -83,000,000 | -75,000,000 | -80,000,000 | -73,000,000 | -77,000,000 | -85,000,000 | -75,000,000 | -76,000,000 | -77,000,000 | -75,000,000 | -75,000,000 | -75,000,000 | -77,000,000 | ||||||||||||||||||||
dividends paid to preferred stockholders | -21,000,000 | -75,000,000 | -21,000,000 | -75,000,000 | -23,000,000 | -75,000,000 | 0 | -75,000,000 | 0 | ||||||||||||||||||||||||||
dividends paid to noncontrolling interest holders | |||||||||||||||||||||||||||||||||||
vistra corp.condensed consolidated statements of cash flows | |||||||||||||||||||||||||||||||||||
tax withholding on stock based compensation | -1,000,000 | 0 | -50,000,000 | ||||||||||||||||||||||||||||||||
principal payment on forward repurchase obligation | 0 | ||||||||||||||||||||||||||||||||||
tra repurchase and tender offer — return of capital | 0 | 0 | 0 | -122,000,000 | |||||||||||||||||||||||||||||||
cash from financing activities | -833,000,000 | -63,000,000 | -164,000,000 | -754,000,000 | -1,661,000,000 | 18,000,000 | 793,000,000 | 196,000,000 | 1,382,000,000 | -998,000,000 | -874,000,000 | -83,000,000 | -1,877,000,000 | 2,293,000,000 | -413,000,000 | 995,000,000 | -392,000,000 | -268,000,000 | 1,939,000,000 | -448,000,000 | -650,000,000 | -750,000,000 | 52,000,000 | -453,000,000 | -614,000,000 | 174,000,000 | -344,000,000 | -551,000,000 | -729,000,000 | -1,434,000,000 | -9,000,000 | -164,000,000 | -10,000,000 | -9,000,000 | -18,000,000 |
net change in cash, cash equivalents and restricted cash | 143,000,000 | -101,000,000 | -626,000,000 | 282,000,000 | -721,000,000 | 545,000,000 | -2,423,000,000 | 314,000,000 | 2,527,000,000 | 125,000,000 | 48,000,000 | -43,000,000 | -1,339,000,000 | 850,000,000 | -302,000,000 | 972,000,000 | -96,000,000 | -118,000,000 | 157,000,000 | -106,000,000 | 117,000,000 | -362,000,000 | 320,000,000 | -278,000,000 | -253,000,000 | 418,000,000 | -105,000,000 | -177,000,000 | 54,000,000 | -1,122,000,000 | -108,000,000 | ||||
cash, cash equivalents and restricted cash — beginning balance | 0 | 0 | 1,222,000,000 | 0 | 0 | 0 | 3,539,000,000 | 0 | 0 | 0 | 525,000,000 | 0 | 0 | 0 | 1,359,000,000 | 0 | 0 | 0 | 444,000,000 | 0 | 0 | 0 | 475,000,000 | 0 | 0 | 0 | 693,000,000 | 0 | 0 | 0 | 2,046,000,000 | ||||
cash, cash equivalents and restricted cash — ending balance | 143,000,000 | -101,000,000 | 596,000,000 | 282,000,000 | -721,000,000 | 545,000,000 | 1,116,000,000 | 314,000,000 | 2,527,000,000 | 125,000,000 | 573,000,000 | -43,000,000 | -1,339,000,000 | 850,000,000 | 1,057,000,000 | 972,000,000 | -96,000,000 | -118,000,000 | 601,000,000 | -106,000,000 | 117,000,000 | -362,000,000 | 795,000,000 | -278,000,000 | -253,000,000 | 418,000,000 | 588,000,000 | -177,000,000 | 54,000,000 | -1,122,000,000 | 1,938,000,000 | ||||
unrealized net income from mark-to-market valuations of commodities | -16,000,000 | 567,000,000 | -320,000,000 | ||||||||||||||||||||||||||||||||
unrealized net (gain) income from mark-to-market valuations of interest rate swaps | 26,000,000 | 48,000,000 | -79,000,000 | -47,000,000 | 41,000,000 | -42,000,000 | -13,000,000 | 9,000,000 | -88,000,000 | -55,000,000 | 76,000,000 | 119,000,000 | 80,000,000 | 128,000,000 | -37,000,000 | ||||||||||||||||||||
net borrowings (repayments) under accounts receivable financing | 43,000,000 | 332,000,000 | 0 | 0 | |||||||||||||||||||||||||||||||
unrealized net (gain) income from nuclear decommissioning trusts | 15,000,000 | ||||||||||||||||||||||||||||||||||
issuances of long-term debt | 1,617,000,000 | 0 | 1,500,000,000 | 700,000,000 | 748,000,000 | 0 | 0 | 0 | 0 | 1,907,000,000 | 0 | 3,300,000,000 | 1,300,000,000 | 0 | |||||||||||||||||||||
gain on sale of land | 0 | -1,000,000 | |||||||||||||||||||||||||||||||||
change in asset retirement obligation liability | |||||||||||||||||||||||||||||||||||
impacts of tax receivable agreement | 0 | 0 | 0 | 5,000,000 | 36,000,000 | 49,000,000 | 14,000,000 | 65,000,000 | 99,000,000 | -86,000,000 | 34,000,000 | 81,000,000 | -22,000,000 | -35,000,000 | 41,000,000 | -37,000,000 | 39,000,000 | -58,000,000 | 6,000,000 | 8,000,000 | 11,000,000 | 62,000,000 | -33,000,000 | -3,000,000 | 14,000,000 | -17,000,000 | 64,000,000 | 18,000,000 | -117,000,000 | -138,000,000 | |||||
gain on tra repurchase and tender offers | 0 | 0 | 0 | -10,000,000 | |||||||||||||||||||||||||||||||
stock-based compensation | 24,000,000 | 23,000,000 | 32,000,000 | 21,000,000 | 14,000,000 | 20,000,000 | 21,000,000 | 22,000,000 | 15,000,000 | 14,000,000 | 20,000,000 | 14,000,000 | 11,000,000 | 11,000,000 | 9,000,000 | 16,000,000 | 19,000,000 | 16,000,000 | 16,000,000 | 14,000,000 | 12,000,000 | 11,000,000 | 12,000,000 | 12,000,000 | 14,000,000 | 0 | 53,000,000 | 6,000,000 | 5,000,000 | 4,000,000 | 4,000,000 | ||||
accounts receivable — trade | |||||||||||||||||||||||||||||||||||
inventories | |||||||||||||||||||||||||||||||||||
accounts payable — trade | |||||||||||||||||||||||||||||||||||
commodity and other derivative contractual assets and liabilities | |||||||||||||||||||||||||||||||||||
uplift securitization proceeds receivable from ercot | 0 | 0 | |||||||||||||||||||||||||||||||||
asset retirement obligation settlement | |||||||||||||||||||||||||||||||||||
major plant outage deferral | |||||||||||||||||||||||||||||||||||
other — net assets | |||||||||||||||||||||||||||||||||||
other — net liabilities | |||||||||||||||||||||||||||||||||||
proceeds from sales of property, plant, and equipment, including nuclear fuel | |||||||||||||||||||||||||||||||||||
proceeds from sales of transferable itcs | |||||||||||||||||||||||||||||||||||
vistra corp. consolidated statements of cash flows | |||||||||||||||||||||||||||||||||||
dividends paid to noncontrolling and redeemable noncontrolling interest holders | |||||||||||||||||||||||||||||||||||
payment for acquisition of noncontrolling interest | |||||||||||||||||||||||||||||||||||
deferred income tax expense | 551,000,000 | 191,000,000 | 60,000,000 | 13,000,000 | 180,000,000 | -13,000,000 | 42,000,000 | ||||||||||||||||||||||||||||
impairment of long-lived assets | 0 | 0 | 272,000,000 | 0 | 84,000,000 | ||||||||||||||||||||||||||||||
unrealized net gain from mark-to-market valuations of commodities | -96,000,000 | -321,000,000 | 2,000,000 | -125,000,000 | |||||||||||||||||||||||||||||||
vistra corp. condensed consolidated statements of cash flows | |||||||||||||||||||||||||||||||||||
dividends paid to noncontrolling interest in subsidiary | 0 | ||||||||||||||||||||||||||||||||||
unrealized net gain from mark-to-market valuations of interest rate swaps | -43,000,000 | -90,000,000 | -45,000,000 | -126,000,000 | |||||||||||||||||||||||||||||||
gain on tra settlement | |||||||||||||||||||||||||||||||||||
insurance proceeds | 1,000,000 | 5,000,000 | 6,000,000 | 3,000,000 | 24,000,000 | 14,000,000 | 0 | 1,000,000 | 15,000,000 | 11,000,000 | 23,000,000 | 40,000,000 | |||||||||||||||||||||||
proceeds from sales of property, plant and equipment | |||||||||||||||||||||||||||||||||||
issuances of preferred stock | |||||||||||||||||||||||||||||||||||
borrowings under term loan a | 0 | 0 | |||||||||||||||||||||||||||||||||
repayment under term loan a | 0 | 0 | |||||||||||||||||||||||||||||||||
proceeds from forward capacity agreement | 0 | 0 | 0 | 500,000,000 | |||||||||||||||||||||||||||||||
net borrowings/(repayments) under accounts receivable financing | |||||||||||||||||||||||||||||||||||
proceeds from sale of assets | 1,000,000 | 108,000,000 | 2,000,000 | 0 | 7,000,000 | 23,000,000 | |||||||||||||||||||||||||||||
net (repayments)/borrowings under accounts receivable financing | 0 | ||||||||||||||||||||||||||||||||||
share repurchases | -314,000,000 | -251,000,000 | -301,000,000 | -359,000,000 | -396,000,000 | -484,000,000 | -710,000,000 | -296,000,000 | 0 | 0 | -175,000,000 | ||||||||||||||||||||||||
loss on disposal of investment in nelp | 0 | 0 | 1,000,000 | 28,000,000 | |||||||||||||||||||||||||||||||
tax receivable agreement payment | |||||||||||||||||||||||||||||||||||
proceeds from sale of nuclear fuel | |||||||||||||||||||||||||||||||||||
net borrowings/(payments) under accounts receivable financing | |||||||||||||||||||||||||||||||||||
debt tender offer and other financing fees | -8,000,000 | 0 | 0 | -7,000,000 | -5,000,000 | -5,000,000 | -24,000,000 | -82,000,000 | -64,000,000 | ||||||||||||||||||||||||||
ambit acquisition | |||||||||||||||||||||||||||||||||||
crius acquisition | 0 | ||||||||||||||||||||||||||||||||||
dividends paid to stockholders | -71,000,000 | -72,000,000 | -73,000,000 | -74,000,000 | -68,000,000 | -66,000,000 | -66,000,000 | -66,000,000 | -62,000,000 | -61,000,000 | -59,000,000 | -61,000,000 | |||||||||||||||||||||||
borrowing under term loan a | 1,000,000,000 | ||||||||||||||||||||||||||||||||||
cash acquired in the merger | 0 | 0 | |||||||||||||||||||||||||||||||||
proceeds from sales of assets | |||||||||||||||||||||||||||||||||||
net borrowings/ | |||||||||||||||||||||||||||||||||||
debt tender offer and other debt financing fees | |||||||||||||||||||||||||||||||||||
stock repurchase | -24,000,000 | -175,000,000 | -209,000,000 | -248,000,000 | -349,000,000 | -351,000,000 | |||||||||||||||||||||||||||||
net borrowings under accounts receivable securitization program | -150,000,000 | 170,000,000 | 80,000,000 | 11,000,000 | |||||||||||||||||||||||||||||||
alcoa contract settlement | |||||||||||||||||||||||||||||||||||
aro settlement | |||||||||||||||||||||||||||||||||||
capital expenditures, including ltsa prepayments | -172,000,000 | -101,000,000 | -129,000,000 | -118,000,000 | |||||||||||||||||||||||||||||||
nuclear fuel purchases | -56,000,000 | -13,000,000 | -7,000,000 | -13,000,000 | -52,000,000 | -38,000,000 | -17,000,000 | -11,000,000 | -6,000,000 | -21,000,000 | -23,000,000 | -12,000,000 | |||||||||||||||||||||||
development and growth expenditures | -11,000,000 | -57,000,000 | -14,000,000 | -22,000,000 | |||||||||||||||||||||||||||||||
odessa acquisition | 0 | ||||||||||||||||||||||||||||||||||
vistra energy corp. consolidated statements of cash flows | |||||||||||||||||||||||||||||||||||
proceeds from sale of environmental allowances | 1,000,000 | ||||||||||||||||||||||||||||||||||
deferred income tax (benefit) expense | 147,000,000 | 70,000,000 | 188,000,000 | -76,000,000 | -83,000,000 | ||||||||||||||||||||||||||||||
gain on extinguishment of liabilities subject to compromise | |||||||||||||||||||||||||||||||||||
net income from adopting fresh start reporting | |||||||||||||||||||||||||||||||||||
contract claims adjustments of predecessor | |||||||||||||||||||||||||||||||||||
write-off of intangible and other assets | |||||||||||||||||||||||||||||||||||
affiliate accounts receivable/payable — net | |||||||||||||||||||||||||||||||||||
debt tender offer and other debt financing fee | |||||||||||||||||||||||||||||||||||
vistra energy corp.statements of consolidated cash flows | |||||||||||||||||||||||||||||||||||
incremental term loan b facility | |||||||||||||||||||||||||||||||||||
special dividend | |||||||||||||||||||||||||||||||||||
net proceeds from issuance of preferred stock | |||||||||||||||||||||||||||||||||||
payments to extinguish claims of tceh first lien creditors | |||||||||||||||||||||||||||||||||||
payment to extinguish claims of tceh unsecured creditors | |||||||||||||||||||||||||||||||||||
borrowings under tceh dip roll facilities and dip facility | |||||||||||||||||||||||||||||||||||
tceh dip roll facilities and dip facility financing fees | |||||||||||||||||||||||||||||||||||
lamar and forney acquisition — net of cash acquired | |||||||||||||||||||||||||||||||||||
changes in restricted cash | 152,000,000 | 3,000,000 | 30,000,000 | 1,000,000 | |||||||||||||||||||||||||||||||
notes/advances due from affiliates | |||||||||||||||||||||||||||||||||||
accretion expense | -7,000,000 | 25,000,000 | 19,000,000 | ||||||||||||||||||||||||||||||||
accrued incentive plan | 14,000,000 | 19,000,000 | -50,000,000 | 14,000,000 | |||||||||||||||||||||||||||||||
borrowing under accounts receivable securitization program | |||||||||||||||||||||||||||||||||||
capital expenditures | -56,000,000 | -114,000,000 | -39,000,000 | -28,000,000 | -23,000,000 | -32,000,000 | -31,000,000 | ||||||||||||||||||||||||||||
solar development expenditures | -7,000,000 | 0 | -21,000,000 | -61,000,000 | -33,000,000 | ||||||||||||||||||||||||||||||
debt financing fee | |||||||||||||||||||||||||||||||||||
unrealized net (gain) income from mark-to-market valuations of derivatives | 356,000,000 | 315,000,000 | -151,000,000 | 81,000,000 | -129,000,000 | ||||||||||||||||||||||||||||||
noncash adjustment for estimated allowed claims related to debt | |||||||||||||||||||||||||||||||||||
adjustment to intercompany claims pursuant to settlement agreement | |||||||||||||||||||||||||||||||||||
impairment of goodwill | |||||||||||||||||||||||||||||||||||
increase in asset retirement obligation liability | |||||||||||||||||||||||||||||||||||
vistra energy corp.condensed statements of consolidated cash flows | |||||||||||||||||||||||||||||||||||
net change in cash and cash equivalents | 433,000,000 | 68,000,000 | 70,000,000 | 73,000,000 | |||||||||||||||||||||||||||||||
cash and cash equivalents — beginning balance | 0 | 0 | 0 | 843,000,000 | |||||||||||||||||||||||||||||||
cash and cash equivalents — ending balance | 433,000,000 | 68,000,000 | 70,000,000 | 916,000,000 | |||||||||||||||||||||||||||||||
other operating assets and liabilities, including liabilities subject to compromise | -33,000,000 | -154,000,000 | -40,000,000 | ||||||||||||||||||||||||||||||||
tceh dip roll facilities financing fees | |||||||||||||||||||||||||||||||||||
borrowings under tceh dip facility | |||||||||||||||||||||||||||||||||||
accrued property taxes | -71,000,000 | ||||||||||||||||||||||||||||||||||
accrued incentive plan payments | -73,000,000 |
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
